Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-82.18	53.73	301.50
Graham Fair Price	174.00	113.40	41.39
PEG	-98.82	0.03	2.69
Price/Book	-10.67	9.34	10.45
Price/Cash Flow	-85.99	45.03	321.40
Prices/Earnings	-85.36	18.33	125.19
Price/Sales	-50.19	26.00	52.21
Price/FCF	-85.99	45.03	321.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	10.21	0.82	0.75
Operating Margin	322.92	0.46	0.11
ROA	536.63	0.08	0.01
ROE	0.02	0.13	510.06
ROIC	0.02	0.10	519.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.01	-91.14
Dividends QOQ	-0.02	< 0.005	-74.61
EBIT QOQ	0.20	7.41	3571.44
EPS QOQ	0.47	5.77	1140.52
FCF QOQ	4.04	6.07	50.36
Revenue QOQ	0.14	0.99	622.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	356.84	0.00	inf
Days Sales Outstanding (DSO)	55.18	20.03	-63.71
Inventory Turnover	0.25	0.00	inf
Debt/Capitalization	0.28	0.24	-12.43
Quick Ratio	0.57	1.00	74.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	60.39	66.99	10.94
Cash	5.32	16.71	214.17
Capex	-0.23	-0.22	3.17
Free Cash Flow	1.96	13.89	607.27
Revenue	12.09	24.06	98.97
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.17	1.50	27.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.34	0.69	-91.71
Naive Interpretation	Member

06 - Financial Health · Weak

Rating